Allopurinol salvage therapy in pediatric overlap autoimmune hepatitis-primary sclerosing cholangitis with 6-MMP toxicity.
Dunkin
David
D
Division of Pediatric Hepatology/RMTI, Mount Sinai School of Medicine, New York, USA. david.dunkin@mssm.edu
Kerkar
Nanda
N
Arnon
Ronen
R
Suchy
Frederick
F
Miloh
Tamir
T
D000493:Allopurinol / Q000627:therapeutic use*; D000963:Antimetabolites / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D015209:Cholangitis, Sclerosing / Q000097:blood / Q000150:complications / Q000188:drug therapy; D005260:Female; D005500:Follow-Up Studies; D019693:Hepatitis, Autoimmune / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D008297:Male; D015122:Mercaptopurine / Q000009:adverse effects* / Q000627:therapeutic use; D016879:Salvage Therapy / Q000379:methods*; D000637:Transaminases / Q000097:blood / Q000187:drug effects
D000963:Antimetabolites; D000493:Allopurinol; D015122:Mercaptopurine; D000637:Transaminases